The Flowflex SARS-CoV-2 Antigen Rapid Test provides an aid in identifying individuals suspected of an active COVID-19 infection by their healthcare provider within the first seven (7) days of the onset of symptoms.

Performance

  • Relative Sensitivity: 97.1% (83.8%-99.9%)*
  • Relative Specificity: 99.6% (97.7%-99.9%)*
  • Accuracy: 99.3% (97.5%-99.9%)*

*95% Confidence Intervals

Test Highlights

  • Cassette Format
  • Detects the nucleocapsid protein antigen from SARS-CoV-2
  • Nasal Specimen sample
  • Results in 15 minutes

Category